LATEST ALERTS
India is far from unique in the high level of misperception about nicotine among its doctors and its politicians. But sometimes the famously fussy bureaucracy can become positively farcical
There remains a worryingly large amount of research on novel nicotine products which makes casual, almost always negative, assumptions…and the occasional item so faulty it should never have been published at all
Broadening the appeal of tobacco harm reduction (THR) products in low- and middle-income countries can be an uphill struggle, though it arguably matters more there than anywhere else
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
